[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558558":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":40,"collaborators":10,"id":42,"slug":10,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Azienda Usl di Bologna","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Percutaneous tracheostomy",null,"Patients receiving percutaneous tracheostomy for any reason during their ICU stay",[13],"Procedure: Percutaneous tracheostomy",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":10},"PROCEDURE","Percutaneous tracheostomy is a widely used technique in intensive care. It involves creating a passage between the tracheal lumen and the outside, through which a cannula is placed.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Lorenzo Gamberini, MD","CONTACT","+393403550540","gamberini6@ausl.bologna.it",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":30,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Maggiore Hospital Carlo Alberto Pizzardi","RECRUITING","Bologna","40024","Italy",{"type":33,"coordinates":34},"Point",[35,36],11.33875,44.49381,{"lat":36,"lon":35},[39],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100558558",false,"NCT06552676","riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU","Risk Factors for Neck Phlegmon After Percutaneous Tracheostomy in ICU","SORCERER","Inclusion Criteria:\n\n* Age greater than 18 years\n* Presence of indication for tracheostomy\n\nExclusion Criteria:\n\n* Failure of the percutaneous tracheostomy technique or recourse to surgical tracheostomy","ALL","18 Years",{"count":52,"type":53},300,"ESTIMATED","OBSERVATIONAL","Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy.\n\nParticipant Population\u002FPrimary Condition: Patients admitted to Intensive Care\n\nMain Questions Aims to Answer:\n\n1. \\- What are the risk factors associated with the development of tracheal phlegmon percutaneous tracheostomy?\n2. \\- How does the appearance of tracheal phlegmon impact intensive care stay, hospital stay, mortality, and Health-related quality of life?\n\nParticipants will be followed up after undergoing tracheostomy for 7 days to identify eventual phlegmons.\n\nAt the two-year follow-up, the health-related quality of life will be assessed",[57,58],"Tracheostomy Complication","Quality of Life","2024-08-10",{"date":61,"type":62},"2024-08-14","ACTUAL",{"date":64,"type":62},"2018-08-09",{"date":66,"type":53},"2025-01-31",{"name":5,"class":6},1]